Document is current
Any future updates will be listed below
-
Authors
Kurnit, Katherine C.
Coleman, Robert L.
Westin, Shannon N.
-
Funding
Funding for this research was provided by:
National Institutes of Health (5 T32 CA101642 02, 2P50 CA109298)
University of Texas MD Anderson Cancer Center (P30CA016672)
- License Information
-
More Information
Article History
First Online: 15 November 2018
Compliance with Ethical Standards
:
: Katherine Kurnit declares that she has no conflict of interest.Robert L. Coleman has received research funding through grants from the National Institutes of Health (NIH), the Gateway Fondation, and the V Foundation; has also received research support from AstraZeneca, Merck, Clovis, Genmab, Roche/Genentech, and Janssen; and has received compensation from AstraZeneca, Tesaro, Medivation, Clovis, GamaMabs, Genmab, Roche/Genentech, Janssen, Agenus, Regeneron, and OncoQuest for service as a consultant.Shannon N. Westin has received research funding through grants from the NIH and the Andrew Sabin Family Fellowship; has also received research support from AstraZeneca, Tesaro, and Cotinga Pharmaceuticals; and has received compensation from AstraZeneca, Merck, Tesaro, Medivation, Clovis, Casdin Capital, Ovation, and Roche/Genentech for service as a consultant.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
